Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study

Background: Postmenopausal osteoporosis is a multifactorial disease. Genetic factors play an essential role in contributing to bone mineral density (BMD) variability, which ranges from 60 to 85%. Alendronate is used as the first line of pharmacological treatment for osteoporosis; however, some patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Villagómez Vega, Alejandra, Gámez Nava, Jorge Iván, Ruiz González, Francisco, Pérez Romero, Misael, Trujillo Rangel, Walter Ángel, Nuño Arana, Ismael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956997/
https://www.ncbi.nlm.nih.gov/pubmed/36833451
http://dx.doi.org/10.3390/genes14020524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956997/
https://www.ncbi.nlm.nih.gov/pubmed/36833451
http://dx.doi.org/10.3390/genes14020524

Ejemplares similares